Jiang Zhu | CSO
Uvax Bio

Jiang Zhu, CSO, Uvax Bio

Trained as a biophysicist, Jiang conducts research in microbiology, immunology, and vaccinology. His laboratory at Scripps Research is developing single-component, multilayered, self-assembling protein nanoparticle (SApNP) vaccines for viral and non-viral pathogens. They currently work on HIV, HCV, Ebola, RSV, and SARS-CoV-2, as well as Malaria and TB. As a co-founder of Uvax Bio, LLC, he hopes to turn our research breakthroughs into real vaccine products that can actually help people. His goal is to rid the world of some of the worst infectious diseases in the next decade.


Day 3 - November 30 @ 11:45

Targeting HIV-1 and Beyond: Novel Protein Nanoparticles as Vaccine Platforms

last published: 02/Jan/24 12:15 GMT

back to speakers